Literature DB >> 25693770

Estimating the burden of recurrent events in the presence of competing risks: the method of mean cumulative count.

Huiru Dong, Leslie L Robison, Wendy M Leisenring, Leah J Martin, Gregory T Armstrong, Yutaka Yasui.   

Abstract

Cumulative incidence has been widely used to estimate the cumulative probability of developing an event of interest by a given time, in the presence of competing risks. When it is of interest to measure the total burden of recurrent events in a population, however, the cumulative incidence method is not appropriate because it considers only the first occurrence of the event of interest for each individual in the analysis: Subsequent occurrences are not included. Here, we discuss a straightforward and intuitive method termed "mean cumulative count," which reflects a summarization of all events that occur in the population by a given time, not just the first event for each subject. We explore the mathematical relationship between mean cumulative count and cumulative incidence. Detailed calculation of mean cumulative count is described by using a simple hypothetical example, and the computation code with an illustrative example is provided. Using follow-up data from January 1975 to August 2009 collected in the Childhood Cancer Survivor Study, we show applications of mean cumulative count and cumulative incidence for the outcome of subsequent neoplasms to demonstrate different but complementary information obtained from the 2 approaches and the specific utility of the former.
© The Author 2015. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cumulative incidence; disease burden; mean cumulative count; recurrent events

Mesh:

Year:  2015        PMID: 25693770      PMCID: PMC4371763          DOI: 10.1093/aje/kwu289

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

2.  Nonparametric analysis of recurrent events and death.

Authors:  D Ghosh; D Y Lin
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

3.  Marginal analysis of recurrent events and a terminating event.

Authors:  R J Cook; J F Lawless
Journal:  Stat Med       Date:  1997-04-30       Impact factor: 2.373

4.  Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study.

Authors:  Gregory T Armstrong; Wei Liu; Wendy Leisenring; Yutaka Yasui; Sue Hammond; Smita Bhatia; Joseph P Neglia; Marilyn Stovall; Deokumar Srivastava; Leslie L Robison
Journal:  J Clin Oncol       Date:  2011-06-27       Impact factor: 44.544

5.  The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks.

Authors:  J Broderick; T Brott; R Kothari; R Miller; J Khoury; A Pancioli; J Gebel; D Mills; L Minneci; R Shukla
Journal:  Stroke       Date:  1998-02       Impact factor: 7.914

Review 6.  The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research.

Authors:  Leslie L Robison; Gregory T Armstrong; John D Boice; Eric J Chow; Stella M Davies; Sarah S Donaldson; Daniel M Green; Sue Hammond; Anna T Meadows; Ann C Mertens; John J Mulvihill; Paul C Nathan; Joseph P Neglia; Roger J Packer; Preetha Rajaraman; Charles A Sklar; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

Review 7.  Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.

Authors:  Anna T Meadows; Debra L Friedman; Joseph P Neglia; Ann C Mertens; Sarah S Donaldson; Marilyn Stovall; Sue Hammond; Yutaka Yasui; Peter D Inskip
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

8.  Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.

Authors:  Leslie L Robison; Ann C Mertens; John D Boice; Norman E Breslow; Sarah S Donaldson; Daniel M Green; Frederic P Li; Anna T Meadows; John J Mulvihill; Joseph P Neglia; Mark E Nesbit; Roger J Packer; John D Potter; Charles A Sklar; Malcolm A Smith; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer
Journal:  Med Pediatr Oncol       Date:  2002-04

9.  Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.

Authors:  Debra L Friedman; John Whitton; Wendy Leisenring; Ann C Mertens; Sue Hammond; Marilyn Stovall; Sarah S Donaldson; Anna T Meadows; Leslie L Robison; Joseph P Neglia
Journal:  J Natl Cancer Inst       Date:  2010-07-15       Impact factor: 11.816

10.  Wei, Lin and Weissfeld's marginal analysis of multivariate failure time data: should it be applied to a recurrent events outcome?

Authors:  Chris Metcalfe; Simon G Thompson
Journal:  Stat Methods Med Res       Date:  2007-04       Impact factor: 3.021

View more
  36 in total

1.  Neurologic disorders in 4858 survivors of central nervous system tumors in childhood-an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study.

Authors:  Line Kenborg; Jeanette Falck Winther; Karen Markussen Linnet; Anja Krøyer; Vanna Albieri; Anna Sällfors Holmqvist; Laufey Tryggvadottir; Laura Maria Madanat-Harjuoja; Marilyn Stovall; Henrik Hasle; Jørgen H Olsen
Journal:  Neuro Oncol       Date:  2019-01-01       Impact factor: 12.300

2.  Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.

Authors:  Lucie M Turcotte; Qi Liu; Yutaka Yasui; Michael A Arnold; Sue Hammond; Rebecca M Howell; Susan A Smith; Rita E Weathers; Tara O Henderson; Todd M Gibson; Wendy Leisenring; Gregory T Armstrong; Leslie L Robison; Joseph P Neglia
Journal:  JAMA       Date:  2017-02-28       Impact factor: 56.272

Review 3.  Surveillance for Late Effects in Childhood Cancer Survivors.

Authors:  Wendy Landier; Roderick Skinner; W Hamish Wallace; Lars Hjorth; Renée L Mulder; F Lennie Wong; Yutaka Yasui; Nickhill Bhakta; Louis S Constine; Smita Bhatia; Leontien C Kremer; Melissa M Hudson
Journal:  J Clin Oncol       Date:  2018-06-06       Impact factor: 44.544

4.  Frailty Screening Using the Electronic Health Record Within a Medicare Accountable Care Organization.

Authors:  Nicholas M Pajewski; Kristin Lenoir; Brian J Wells; Jeff D Williamson; Kathryn E Callahan
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-10-04       Impact factor: 6.053

5.  Cumulative Burden of Chronic Health Conditions in Adult Survivors of Osteosarcoma and Ewing Sarcoma: A Report from the St. Jude Lifetime Cohort Study.

Authors:  Michael W Bishop; Kirsten K Ness; Chenghong Li; Wei Liu; Deo Kumar Srivastava; Wassim Chemaitilly; Kevin R Krull; Daniel M Green; Alberto S Pappo; Leslie L Robison; Melissa M Hudson; Daniel A Mulrooney
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-06-04       Impact factor: 4.254

6.  Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial.

Authors:  Nicholas M Pajewski; Jeff D Williamson; William B Applegate; Dan R Berlowitz; Linda P Bolin; Glenn M Chertow; Marie A Krousel-Wood; Nieves Lopez-Barrera; James R Powell; Christianne L Roumie; Carolyn Still; Kaycee M Sink; Rocky Tang; Clinton B Wright; Mark A Supiano
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-01-11       Impact factor: 6.053

7.  Chronic disease burden and frailty in survivors of childhood HSCT: a report from the St. Jude Lifetime Cohort Study.

Authors:  Hesham M Eissa; Lu Lu; Malek Baassiri; Nickhill Bhakta; Matthew J Ehrhardt; Brandon M Triplett; Daniel M Green; Daniel A Mulrooney; Leslie L Robison; Melissa M Hudson; Kirsten K Ness
Journal:  Blood Adv       Date:  2017-11-07

Review 8.  New Agents, Emerging Late Effects, and the Development of Precision Survivorship.

Authors:  Eric J Chow; Zoltan Antal; Louis S Constine; Rebecca Gardner; W Hamish Wallace; Brent R Weil; Jennifer M Yeh; Elizabeth Fox
Journal:  J Clin Oncol       Date:  2018-06-06       Impact factor: 44.544

9.  Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.

Authors:  Jeff D Williamson; Mark A Supiano; William B Applegate; Dan R Berlowitz; Ruth C Campbell; Glenn M Chertow; Larry J Fine; William E Haley; Amret T Hawfield; Joachim H Ix; Dalane W Kitzman; John B Kostis; Marie A Krousel-Wood; Lenore J Launer; Suzanne Oparil; Carlos J Rodriguez; Christianne L Roumie; Ronald I Shorr; Kaycee M Sink; Virginia G Wadley; Paul K Whelton; Jeffrey Whittle; Nancy F Woolard; Jackson T Wright; Nicholas M Pajewski
Journal:  JAMA       Date:  2016-06-28       Impact factor: 56.272

Review 10.  Current and coming challenges in the management of the survivorship population.

Authors:  Eric J Chow; Kirsten K Ness; Gregory T Armstrong; Nickhill Bhakta; Jennifer M Yeh; Smita Bhatia; Wendy Landier; Louis S Constine; Melissa M Hudson; Paul C Nathan
Journal:  Semin Oncol       Date:  2020-03-04       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.